InceptionR’s Jazz Pharmaceuticals JAZZ Stock Holding History

InceptionR’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,877	Closed	-$489K	–	775
2025 Q4	$489K	Buy	+2,877	New	+$441K	0.14%	287
2024 Q4	–	Sell	-10,075	Closed	-$1.12M	–	743
2024 Q3	$1.12M	Buy	+10,075	New	+$1.1M	0.27%	105
2024 Q2	–	Sell	-5,378	Closed	-$648K	–	723
2024 Q1	$648K	Buy	+5,378	New	+$659K	0.17%	238
2023 Q4	–	Sell	-5,687	Closed	-$736K	–	446
2023 Q3	$736K	Buy	+5,687	New	+$758K	0.42%	60

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

InceptionR's JAZZ Position: Q1 2026 in Review

InceptionR sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2026, closing a stake of 2,877 shares — an estimated $489K sold.

InceptionR first reported a position in JAZZ in Q3 2023 and held it in 4 quarters. The position peaked at $1.12M in Q3 2024. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

InceptionR reported no remaining Jazz Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
InceptionR sold 2,877 Jazz Pharmaceuticals shares in Q1 2026, an estimated $489K.
InceptionR first reported a position in Jazz Pharmaceuticals in Q3 2023 and held it in 4 quarters.
InceptionR's Jazz Pharmaceuticals position peaked at $1.12M in Q3 2024.
570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on InceptionR's 13F filing for Q1 2026, filed 14 May 2026.